ArticleCell death & disease2026

LSD1-GLS2 axis drives subtype-specific chemoresistance in pancreatic cancer through glutaminolysis reprogramming.

Zhefang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.